Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Federal Trade Commission
Accenture
Queensland Health
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson
Medtronic

Generated: October 19, 2018

DrugPatentWatch Database Preview

Alkem Labs Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for ALKEM LABS LTD, and what generic and branded alternatives to ALKEM LABS LTD drugs are available?

ALKEM LABS LTD has thirty-seven approved drugs.

There are seven tentative approvals on ALKEM LABS LTD drugs.

Summary for Alkem Labs Ltd
US Patents:0
Tradenames:34
Ingredients:34
NDAs:37

Drugs and US Patents for Alkem Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd RABEPRAZOLE SODIUM rabeprazole sodium TABLET, DELAYED RELEASE;ORAL 208644-001 Apr 24, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 209042-001 Aug 14, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd AZELASTINE HYDROCHLORIDE azelastine hydrochloride SPRAY, METERED;NASAL 208156-001 Aug 18, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 204453-002 Sep 28, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd DULOXETINE HYDROCHLORIDE duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 203197-003 Aug 26, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cerilliant
Harvard Business School
Accenture
Cipla
Chubb
UBS
Chinese Patent Office
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.